Artificial Heart Market is Increasing Burden of Patients Successfully is Likely to Lead to Growth Over 2030 :

Pune, India, 2022/MRFR Press Release/- Market Research Future has Published a Half-Cooked Research Report on the Global Artificial Heart Market.

Market Highlights

The Artificial Heart Market is anticipated to reach USD 4.98 Billion by 2030 at a 15.80% CAGR during the forecast period 2022-2030. An artificial heart is a prosthetic device that is implanted into the body to provide circulation and replace heart ventricles that are diseased or damaged


The global artificial heart market has been segmented into type, and end user. By type, the market has been segmented into the heart-lung machine and mechanical heart. The mechanical heart is further segmented into total artificial hearts and ventricular assist devices (VADs). The mechanical heart segment is expected to register the highest CAGR during the forecast period due to growing demand.

On the basis of end user, the market has been segmented into Hospitals & Clinics, Specialty Centers, and others.

Key Players

Some of the prominent players in the global artificial heart market are SynCardia Systems, LLC, BiVACOR Inc., CARMAT, Cleveland Heart, Inc., ABIOMED, CryoLife, Inc., Abbott, and Thoratec Corporation.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Artificial Heart Market Research Report

Regional Analysis

On a regional basis, the Americas is anticipated to dominate the global artificial heart market owing to the owing to increasing geriatric population, high prevalence of various chronic diseases, and a large number of diagnostic imaging centers.

Additionally, rising demand for advanced treatment and growing healthcare expenditure is driving the growth of the market. For instance, according to the American College of Cardiology Foundation, coronary heart disease (CHD) is the leading cause of deaths attributable to CV in the US. CHD contributes to over 43.8% of death cases in the US. Additionally, in 2015, the total healthcare expenditure for CVD and stroke in the US was an estimated USD 329.7 billion. CVD and stroke accounted for 14% of total health expenditures in 2015.

Europe accounts for the second largest market and holds a healthy share in the global artificial heart market due to major driving factors like availability of advanced treatment facilities, increasing healthcare expenditure, and flourishing medical device industry due to the presence of major market players.

Asia-Pacific is expected to be the fastest growing market, owing to the huge patient pool, a faster adaptation of healthcare technology, government initiatives to increase the healthcare quality, and availability of favorable insurance policies.

The Middle East & Africa is expected to show the least growth in the market due to some major factors such as lack of awareness, limited access, and availability of treatment facilities. In the Middle East, the United Arab Emirates and Saudi Arabia is the largest market share owing to the development of the healthcare industry and the rising availability of specialty care centers. 

Industry Updates

August 2019 - researchers at the University of Birmingham have developed a device that could improve care for patients with artificial heart pumps. Sometimes, patients waiting for a heart transplant opt for a left ventricular assist device (LVAD), commonly known as a heart pump. It requires an open heart surgery to restore normal blood flow of the heart and patients require to carry the device all the time, which can significantly impact the life of the individual. The new research has developed a patient reported outcome measure (PROM), which is likely to improve clinical care for such patients. It would also help to provide recommendations for future policies, designs, and research.